Lenalidomide news

All news on Lenalidomide (also known as Revlimid): plants, production capacities, investments and involved companies.

18 November 2025
Genmab's EPKINLY Combination Approved by FDA for Relapsed Follicular Lymphoma
EPKINLY + R² shows superior progression-free survival and response rates in Phase 3 trial for relapsed follicular lymphoma, with a consistent safety profile.

Who will be producing Lenalidomide in the future?

Find out with chemXplore Analytics